Davis Todd C
CIK 1392029
Transactions on file
14
Open-market buys
5
Win rate (buys)
60%
5 scored
Avg % since filing (buys)
+109.2%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-06-30 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Other | 132 | $21.2K | +85.1% | open → |
| 2026-06-15 | 2026-06-11 | PTHS Pelthos Therapeutics Inc. | Director | Buy | 503 | $14.4K | -4.0% | open → |
| 2026-06-15 | 2026-06-11 | PTHS Pelthos Therapeutics Inc. | Director | Buy | 35,445 | $985.5K | -0.8% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Grant | 20,784 | $0.00 | — | open → |
| 2025-02-19 | 2025-02-15 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Tax | 4,255 | $510.6K | +147.9% | open → |
| 2025-02-19 | 2025-02-14 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Tax | 6,966 | $835.9K | +147.9% | open → |
| 2025-02-19 | 2025-02-15 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Tax | 2,231 | $267.7K | +147.9% | open → |
| 2025-03-06 | 2025-03-04 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Grant | 21,382 | $0.00 | — | open → |
| 2025-05-13 | 2025-05-09 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Buy | 5,523 | $583.6K | +181.5% | open → |
| 2025-05-13 | 2025-05-09 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Buy | 2,307 | $241.2K | +184.6% | open → |
| 2025-05-13 | 2025-05-09 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Buy | 1,680 | $175.7K | +184.5% | open → |
| 2025-12-08 | 2025-12-04 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Gift | 130 | $0.00 | — | open → |
| 2025-07-02 | 2025-06-30 | LGND LIGAND PHARMACEUTICALS INC | OfficerDirector Chief Executive Officer | Other | 233 | $21.2K | +226.6% | open → |
| 2025-07-03 | 2025-07-01 | PTHS Pelthos Therapeutics Inc. | Director10% | C | 1,500,000 | $15.00M | +175.9% | open → |
